The investor previously made a 172.29% total return on NBIS, starting purchases around $70 and completely exiting the position by selling at $239.31. They are currently avoiding repurchasing NBIS despite price drops into the $150 range, citing concerns that Neoclods are a temporary, unprofitable solution. However, they outlined potential re-entry buy targets at $150 (for a 2% position), $120 (adding 2%), and $100 (adding 2%).